Jove
Visualize
Contact Us

Related Experiment Videos

What is an ideal cardioplegic solution?

H S Saw

    Annals of the Academy of Medicine, Singapore
    |April 1, 1981
    PubMed
    Summary
    This summary is machine-generated.

    Chemical cardioplegia protects the heart during surgery. Experimental models at University Hospital, Kuala Lumpur, confirmed the safety and efficacy of their myocardial protection solution.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The expression of epidermal growth factor receptor, vascular endothelial growth factor, matrix metalloproteinase-2, and cyclooxygenase-2 in relation to human papilloma viral load and persistence of human papillomavirus after conization with negative margins.

    International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2006
    Same author

    Natural history of low-grade squamous intraepithelial lesion.

    Journal of lower genital tract disease·2006
    Same author

    Finger-assisted stretching technique for cesarean section.

    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2006
    Same author

    Detection of epidermal growth factor receptor in the serum of patients with cervical carcinoma.

    Clinical cancer research : an official journal of the American Association for Cancer Research·2001
    Same author

    Tissue scar formation after transmyocardial laser revascularization.

    The Journal of cardiovascular surgery·2000
    Same author

    Hybrid cardiac revascularisation surgery.

    Singapore medical journal·2000
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies

    Area of Science:

    • Cardiology
    • Biochemistry
    • Cell Biology

    Background:

    • Chemical cardioplegia is widely used for intra-operative myocardial protection.
    • Clinical evidence supporting cardioplegic solutions is abundant, yet experimental data is limited.

    Purpose of the Study:

    • To evaluate the efficacy and safety of commonly used cardioplegic solutions.
    • To develop experimental models for testing cardioplegic solutions in vitro and in vivo.

    Main Methods:

    • Development of experimental models at University Hospital, Kuala Lumpur.
    • In vivo and in vitro testing of cardioplegic solutions.
    • Assessment of biochemical and electronmicroscopic changes.

    Main Results:

    Related Experiment Videos

  • The cardioplegic solution used at University Hospital was found to be safe.
  • The solution demonstrated effectiveness in myocardial protection.
  • Biochemical and electronmicroscopic data supported the findings.

    • Conclusions:

    • The cardioplegic solution employed at University Hospital is safe and effective for myocardial protection.
    • Further research using these experimental models could define an ideal cardioplegic solution composition.